Strides Pharma to manufacture Pfizer’s Covid-19 drug

Strides Pharma to manufacture Pfizer’s Covid-19 drug

The drug consists of Nirmatrelvir tablets, which are co-packaged and co-administered with Ritonavir tablets. Strides Pharma Science on Monday announced a sub-licensing agreement with the Medicines Patent Pool (MPP) to commercialise a generic version of Pfizer’s Covid-19 oral treatment in 95 low and middle-income markets. Pfizer’s Covid-19 oral treatment has received the US Food and … Read more

Balacovin: Kerala firm PNB Vesper Life gets nod for phase 3 clinical trial of Covid drug

oxygen hospital

There are 28 post-covid long-term complications that the WHO has identified. (Representational Image) A Covid-19 drug manufactured by Kerala-based company, PNB Vesper, has received nod by DCGI to conduct Phase 3 clinical trials. The company will be conducting a nationwide multi-centred clinical trial of the drug- PNB-001 (GPP-BALACOVIN), on Covid-19 patients who are hospitalised and … Read more

First Covid patient treated with ‘antibody cocktail’ discharged; Here’s where to get it and its price per dose

Roches antibody therapy

The drug cocktail has clocked reduced hospitalisation and death by upto 70 per cent India has striated administering Roche’s antibody cocktail treatment to Covid-19 patients and the first patients to receive it, an 84-year-old in Haryana has also been discharged after undergoing critical care at Medanta Hospital. The procedure gained popularity after it was used … Read more

Covid-19: Dr. Reddy’s terminates study of Coronavirus drug Avigan in Kuwait; here’s why

Avigan

Covid-19 update: However, Dr. Reddy’s will continue a late-stage North American trial of Avigan in patients with mild to moderate Covid-19 symptoms. (Reuters image) Covid- 19 update: Indian pharmaceutical giant Dr. Reddy’s Laboratories on Wednesday said that it had terminated its clinical study of Fujifilm Holdings’ COVID-19 drug Avigan in patients with moderate to severe … Read more

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

photo

BRUSSELS: A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated Oct. 30, says the priorities are to secure monoclonal antibodies in a tight … Read more

COVID-19 treatment: PNB Vesper Life Sciences’ new drug gets approval for mid-stage trial

drugs 2

Many pharma companies have been focusing on repurposing older drugs that were approved previously during the pandemic. Kochi-based pharmaceutical firm PNB Vesper Life Sciences has developed a new drug that can be used for the treatment of the novel Coronavirus if approved. The company has received a go-ahead for mid-stage trials of GPP-Baladol on COVID-19 … Read more